We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Syndax Pharma’s Cancer Drug Induces Complete Leukemia Remission
Syndax Pharma’s Cancer Drug Induces Complete Leukemia Remission
Syndax Pharmaceuticals announced that its targeted cancer therapy, SNDX-5613, induced complete remission for certain advanced leukemia patients in an early-stage study.